Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study.

Saved in:
Bibliographic Details
Title: Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study.
Authors: Qian S; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Xu D; Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing, China., Xu Y; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Qi H; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Liang P; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 May 29; Vol. 17, pp. 1833093. Date of Electronic Publication: 2026 May 29 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2026.1833093